230 related articles for article (PubMed ID: 15378407)
1. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
3. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
4. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
[TBL] [Abstract][Full Text] [Related]
5. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
[TBL] [Abstract][Full Text] [Related]
6. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.
Yoshikawa Y; Ueda E; Kojima Y; Sakurai H
Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182
[TBL] [Abstract][Full Text] [Related]
7. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
8. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
[TBL] [Abstract][Full Text] [Related]
9. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities.
Adachi Y; Yoshikawa Y; Sakurai H
Biofactors; 2007; 29(4):213-23. PubMed ID: 18057552
[TBL] [Abstract][Full Text] [Related]
11. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and pharmacokinetic studies of anti-diabetic tropolonato-Zn(II) complexes with Zn(S(2)O(2)) coordination mode.
Murakami H; Yasui H; Yoshikawa Y
Chem Pharm Bull (Tokyo); 2012; 60(9):1096-104. PubMed ID: 22976316
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes.
Yoshikawa Y; Adachi Y; Yasui H; Hattori M; Sakurai H
Chem Pharm Bull (Tokyo); 2011; 59(8):972-7. PubMed ID: 21804241
[TBL] [Abstract][Full Text] [Related]
14. New insulinomimetic zinc(II) complexes of alpha-amino acids and their derivatives with Zn(N2O2) coordination mode.
Yoshikawa Y; Ueda E; Suzuki Y; Yanagihara N; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2001 May; 49(5):652-4. PubMed ID: 11383627
[TBL] [Abstract][Full Text] [Related]
15. Complexes of hydroxy(thio)pyrone and hydroxy(thio)pyridinone with Zn(II) and Mo(VI). Thermodynamic stability and insulin-mimetic activity.
Chaves S; Jelic R; Mendonça C; Carrasco M; Yoshikawa Y; Sakurai H; Santos MA
Metallomics; 2010 Mar; 2(3):220-7. PubMed ID: 21069160
[TBL] [Abstract][Full Text] [Related]
16. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.
Hiromura M; Nakayama A; Adachi Y; Doi M; Sakurai H
J Biol Inorg Chem; 2007 Nov; 12(8):1275-87. PubMed ID: 17805585
[TBL] [Abstract][Full Text] [Related]
17. Anti-hyperglycemic Effect of Long-Term Bis(hinokitiolato)zinc Complex ([Zn(hkt)
Naito Y; Yoshikawa Y; Shintani M; Kamoshida S; Kajiwara N; Yasui H
Biol Pharm Bull; 2017; 40(3):318-326. PubMed ID: 28250273
[TBL] [Abstract][Full Text] [Related]
18. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
19. Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies.
Ueda E; Yoshikawa Y; Ishino Y; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):337-40. PubMed ID: 11911195
[TBL] [Abstract][Full Text] [Related]
20. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
Adachi Y; Sakurai H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
